Literature DB >> 27662322

Role of Glutamate and NMDA Receptors in Alzheimer's Disease.

Rui Wang1, P Hemachandra Reddy1,2,3,4,5,6.   

Abstract

Excitatory glutamatergic neurotransmission via N-methyl-d-aspartate receptor (NMDAR) is critical for synaptic plasticity and survival of neurons. However, excessive NMDAR activity causes excitotoxicity and promotes cell death, underlying a potential mechanism of neurodegeneration occurred in Alzheimer's disease (AD). Studies indicate that the distinct outcomes of NMDAR-mediated responses are induced by regionalized receptor activities, followed by different downstream signaling pathways. The activation of synaptic NMDARs initiates plasticity and stimulates cell survival. In contrast, the activation of extrasynaptic NMDARs promotes cell death and thus contributes to the etiology of AD, which can be blocked by an AD drug, memantine, an NMDAR antagonist that selectively blocks the function of extrasynaptic NMDARs.

Entities:  

Keywords:  Alzheimer’s disease; NMDA receptors; excitotoxicity; extrasynaptic NMDA receptors; glutamate; memantine

Mesh:

Substances:

Year:  2017        PMID: 27662322      PMCID: PMC5791143          DOI: 10.3233/JAD-160763

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  72 in total

1.  Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation.

Authors:  Chianping Ye; Dominic M Walsh; Dennis J Selkoe; Dean M Hartley
Journal:  Neurosci Lett       Date:  2004-08-19       Impact factor: 3.046

2.  Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity.

Authors:  Ruslan I Stanika; Natalia B Pivovarova; Christine A Brantner; Charlotte A Watts; Christine A Winters; S Brian Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

3.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

Review 4.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

Review 5.  Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity.

Authors:  C W Cotman; D T Monaghan; A H Ganong
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

6.  Beta-amyloid oligomers induce early loss of presynaptic proteins in primary neurons by caspase-dependent and proteasome-dependent mechanisms.

Authors:  Bong Geum Jang; Sua In; Boyoung Choi; Min-Ju Kim
Journal:  Neuroreport       Date:  2014-11-12       Impact factor: 1.837

7.  Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

Authors:  E Masliah; M Alford; R DeTeresa; M Mallory; L Hansen
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

8.  Beta-amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism.

Authors:  Paz Fernández-Tomé; Begoña Brera; María-Angeles Arévalo; María L de Ceballos
Journal:  Neurobiol Dis       Date:  2004-04       Impact factor: 5.996

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.

Authors:  J W Geddes; H Chang-Chui; S M Cooper; I T Lott; C W Cotman
Journal:  Brain Res       Date:  1986-12-03       Impact factor: 3.252

View more
  180 in total

1.  PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Aβ42 toxicity.

Authors:  Yifan Yu; Teresa Niccoli; Ziyu Ren; Nathaniel S Woodling; Benjamin Aleyakpo; Gyorgy Szabadkai; Linda Partridge
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

2.  A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.

Authors:  P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Ifenprodil Attenuates Methamphetamine-Induced Behavioral Sensitization Through the GluN2B-PP2A-AKT Cascade in the Dorsal Striatum of Mice.

Authors:  Gang Chen; Tao Li; Jing Xiao; Jing Wang; Qing Shang; Hongyan Qian; Chuchu Qiao; Ping Zhang; Teng Chen; Xinshe Liu
Journal:  Neurochem Res       Date:  2020-01-24       Impact factor: 3.996

Review 4.  Effects of Peroxiredoxin 2 in Neurological Disorders: A Review of its Molecular Mechanisms.

Authors:  Jifei Liu; Gang Su; Juan Gao; Ye Tian; Xiaoyan Liu; Zhenchang Zhang
Journal:  Neurochem Res       Date:  2020-01-30       Impact factor: 3.996

Review 5.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Oligomeric Aβ in the monkey brain impacts synaptic integrity and induces accelerated cortical aging.

Authors:  Danielle Beckman; Sean Ott; Kristine Donis-Cox; William G Janssen; Eliza Bliss-Moreau; Peter H Rudebeck; Mark G Baxter; John H Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

7.  High Ethanol and Acetaldehyde Inhibit Glutamatergic Transmission in the Hippocampus of Aldh2-Knockout and C57BL/6N Mice: an In Vivo and Ex Vivo Analysis.

Authors:  Mostofa Jamal; Asuka Ito; Naoko Tanaka; Takanori Miki; Kiyoshi Ameno; Hiroshi Kinoshita
Journal:  Neurotox Res       Date:  2020-02-15       Impact factor: 3.911

8.  High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease.

Authors:  Tommaso Nuzzo; Andrea Mancini; Mattia Miroballo; Alessia Casamassa; Anna Di Maio; Giorgia Donati; Giulia Sansone; Lorenzo Gaetani; Federico Paolini Paoletti; Andrea Isidori; Paolo Calabresi; Francesco Errico; Lucilla Parnetti; Alessandro Usiello
Journal:  Amino Acids       Date:  2021-02-22       Impact factor: 3.520

Review 9.  Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Ghulam Md Ashraf; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

Review 10.  Olive Oil Polyphenols in Neurodegenerative Pathologies.

Authors:  Constantinos Salis; Louis Papageorgiou; Eleni Papakonstantinou; Marianna Hagidimitriou; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.